Prevatac exisulind: Completed Phase III trial enrollment

Cell Pathways Inc. (CLPA), Horsham, Penn. Product: Prevatac exisulind Business: Cancer Therapeutic category: Apoptosis Target: cGMP-PDE Description: Sulfone metabolite of sulindac Indication: Treat pr...